F-18 FDG uptake in pulmonary lymphangioleiomyomatosis

Clinical Nuclear Medicine

Volumn 26, Issue 12, 2001, Pages 1050-1051

  Pandit, Neeta ^a   Yeung, Henry W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Fluorodeoxyglucose; Lung cancer; Lymphangioleiomyomatosis; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; LUNG CARCINOMA; LUNG TUMOR; LYMPHANGIOLEIOMYOMATOSIS; POSITRON EMISSION TOMOGRAPHY; WHOLE BODY SCINTISCANNING;

FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; MIDDLE AGED; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035190903     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200112000-00021     Document Type: Article

References (5)

1. Clinical experience of lymphangioleiomyomatosis in the UK
2. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis
3. Pulmonary lymphangioleiomyomatosis: Correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests
4. Clear cell 'sugar' tumor of the lung: Association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis
5. Bronchioloalveolar carcinoma: False negative results on FDG-PET